Results

Total Results: 3,870 records

Showing results for "disease".

41. Appropriate Emergency Department Blood Testing for Children with Sickle Cell Disease (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-215-scd-ed-tech-specs.pdf
    June 02, 2025 - Appropriate Emergency Department Blood Testing for Children with Sickle Cell Disease Sickle Cell … Disease Measure 14: Appropriate Emergency Department Blood Testing for Children with Sickle Cell … Disease Description The percentage of children identified as having Sickle Cell Disease presenting … Hb F,S,C 282.63, 282.64 Hb SD-disease Hb F,S,D 282.68, 282.69 Hb SS-disease (sickle cell anemia) Hb … Hb F,C 282.7 Hb E-disease Hb F,E 282.7 Hb H-disease Hb F,H 282.49 Hb SE-disease Hb F,S,E 282.68,

42. Health and economic outcomes of newborn screening for infantile-onset Pompe disease (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/priority-populations/richardson-et-al-2020.pdf
    January 01, 2020 - and treatment with ERT; and (2) NBS for Pompe disease and treatment of infantile-onset disease with … (atypical) Pompe disease without cardiomyopathy, and 60 have late-onset Pompe disease. … Other countries also cite additional considerations for treatments for rare diseases but have not put … may be cost-effective in the context of rare diseases. … The New York pilot newborn screening program for lyso- somal storage diseases: report of the first 65,000

43. Cholesterol Management Evidence and Resources | Agency for Healthcare Research and Quality
    www.ahrq.gov/evidencenow/projects/heart-health/evidence/cholesterol.html
    March 01, 2021 - increased risk for heart attack and stroke, including those with diabetes; those with existing heart disease … USPSTF) released recommendations supporting statin use in adults at increased risk of cardiovascular disease … Recommendation: The USPSTF recommended starting statin use for primary prevention of cardiovascular disease … those with known heart disease, those with high LDL cholesterol levels, and those with diabetes), who … , diabetes, high LDL cholesterol, or elevated risk of heart disease.

44. Chart Abstraction Instructions - Aspirin Use in Ischemic Vascular Disease (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/chart-abstraction-instructions-aspirin.pdf
    June 02, 2025 - Chart Abstraction Instructions - Aspirin Use in Ischemic Vascular Disease 1 Chart Abstraction … Instructions - Aspirin Use in Ischemic Vascular Disease Part 1:  First, determine the Measurement … We will be looking at patients diagnosed with ischemic vascular disease (IVD) for the antithrombotic … Chart Abstraction Instructions - Aspirin Use in Ischemic Vascular Disease 3 ☐ Yes – Meets medical … Chart Abstraction Instructions - Aspirin Use in Ischemic Vascular Disease 4 ☐ Yes – Meets

45. Screening for Asymptomatic Coronary Artery Disease: Systematic Evidence Review (pdf file)
    www.ahrq.gov/downloads/pub/prevent/pdfser/chdser.pdf
    December 08, 2003 - Screening for Asymptomatic Coronary Artery Disease 2 Introduction Coronary heart disease (CHD … of disease in those testing positive is from 28% to 47% (and 2.4% to 4% for probability of disease … Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death … diseases and all causes in men and women. … (false positives) Probability of disease in those testing positive = 3.4% Probability of disease

46. Q-METRIC Sickle Cell Disease Measure 1 Section 1 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-132-scd-section-1.pdf
    October 01, 2013 - Q-METRIC Sickle Cell Disease Measure 1 Section 1     …   Q-METRIC Sickle Cell Disease Measure 1: Timeliness … of Confirmatory Testing for Sickle Cell Disease Graphics for Section I. … Hb F,S,C Hb SD-disease Hb F,S,D Hb SS-disease (sickle cell anemia) Hb F,S Hb SV-disease (unidentified … Hb F,E 282.7 Hb H-disease Hb F,H 282.49 Hb SE-disease Hb F,S,E 282.68, 282.69 Hb C-carrier Hb

47. Section 8: The Care Management Evidence Base (continued) | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/medicaidmgmt/mm8c.html
    October 01, 2014 - Designing and Implementing Medicaid Disease and Care Management Programs Section 8: The Care Management … "Feeling mastery over disease." … Action plans for chronic obstructive pulmonary disease. … Resource utilization in home health chronic obstructive pulmonary disease management. … on coronary artery disease (CAD), we reviewed five relevant articles.

48. Table 8: Prevalence of selected conditions among adults with diabetes by project site. Fiscal year 2010. | Agency for Healthcare Research and Quality
    www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chap5tab8.html
    December 01, 2017 - Project site  Hypertension Any cardiovascular diseases (CVD) Renal disease or failure Amputations … Mental health disorders Liver disease Percent Percent Percent Percent Percent Percent … All project sites 77.9% 31.6% 13.3% 2.4% 23.5% 6.8% CVD includes ischemic heart disease … , congestive heart failure (CHF) and other forms of heart disease, cerebrovascular disease and vascular … disease.

49. Appendix B: Patient age, health status, and IHS total treatment costs by diabetes stage. Fiscal year 2010 | Agency for Healthcare Research and Quality
    www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/appendixb.html
    December 01, 2017 - Diabetes and hypertension excludes persons with diabetes and cardiovascular disease (CVD); they are … Some persons in Stage 7 have hypertension, amputation related procedures, and renal disease or renal … Diabetes and amputation or renal disease and Stage 6. Diabetes and renal failure had CVD. … CVD: Cardiovascular disease   Table B.2. … Diabetes and amputation or renal disease c 4,734 2.0% 22.8% 59.0% 70.2% 74.3% 30.0%

50. Appropriate Antibiotic Prophylaxis for Children With Sickle Cell Disease (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0138-fullreport.pdf
    April 01, 2018 - Prophylaxis for Children with Sickle Cell Disease Section 1. … pneumoniae disease in children with SCD. … addressing childhood obesity may have implications for the subsequent development of cardiovascular diseases … Population estimates of sickle cell disease in the U.S. … Management of sickle cell disease. N Engl J Med 1999; 340(13):1021-30.

51. Q-METRIC Sickle Cell Disease Measure 1, Table 3 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-132-scd-section-5-table-3.pdf
    October 01, 2013 - Q-METRIC Sickle Cell Disease Measure 1, Table 3       … Q-METRIC Sickle Cell Disease Measure 1: Timeliness of Confirmatory Testing for Sickle … Cell Disease Graphics for Section V. … Newborn screening for sickle cell disease: effect on mortality. … The Management of Sickle Cell Disease. No. 02‐ 2117.

52. Q-METRIC Sickle Cell Disease Measure 1, Table 4 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-132-scd-section-7-table-4.pdf
    October 01, 2013 - Q-METRIC Sickle Cell Disease Measure 1, Table 4     … Q-METRIC Sickle Cell Disease Measure 1: Timeliness of Confirmatory Testing for Sickle … Cell Disease Graphics for Section VII.A Identification of Disparities VII.A Race/Ethnicity Table

53. Q-METRIC Sickle Cell Disease Measure 1, Table 5 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-132-scd-section-7-table-5.pdf
    October 01, 2013 - Q-METRIC Sickle Cell Disease Measure 1, Table 5         Q-METRIC Sickle … Cell Disease Measure 1: Timeliness of Confirmatory Testing for Sickle Cell Disease Graphics for Section

54. Q-METRIC Sickle Cell Disease Measure 1, Table 6 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-132-scd-section-7-table-6.pdf
    October 01, 2013 - Q-METRIC Sickle Cell Disease Measure 1, Table 6     Q-METRIC Sickle … Cell Disease Measure 1: Timeliness of Confirmatory Testing for Sickle Cell Disease Graphics for Section

55. Control Cholesterol Numbers: Patient Education Booklet (Spanish) | Agency for Healthcare Research and Quality
    www.ahrq.gov/evidencenow/heart-health/cholesterol/control-spn.html
    September 01, 2018 - about cholesterol levels and diet and exercise guidelines for lowering cholesterol levels and heart disease … Document author(s)/institution of origin: University of Texas, School of Public Health; Centers for Disease … Number of pages: 24 Target audience: Spanish-speaking patients Acknowledgements: Centers for Disease … Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion Date:

56. Control Cholesterol Numbers: Patient Education Booklet | Agency for Healthcare Research and Quality
    www.ahrq.gov/evidencenow/heart-health/cholesterol/control.html
    September 01, 2018 - about cholesterol levels and diet and exercise guidelines for lowering cholesterol levels and heart disease … Document author(s)/institution of origin: University of Texas, School of Public Health; Centers for Disease … audience: Patients, particularly those of Latino or Hispanic descent Acknowledgements: Centers for Disease … Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion Date:

57. Evidence for Advancing Heart Health | Agency for Healthcare Research and Quality
    www.ahrq.gov/evidencenow/projects/heart-health/evidence/index.html
    March 01, 2021 - Evidence for Advancing Heart Health Heart disease is the leading cause of death for men and … attacks, health care professionals can work with their patients to adopt the ABCS of cardiovascular disease … Cholesterol management Smoking cessation Clinical evidence about how best to prevent cardiovascular disease

58. Appendix B. Health Outcomes Reported in Transforming Primary Care Studies | Agency for Healthcare Research and Quality
    www.ahrq.gov/ncepcr/research-transform-primary-care/transform/synthesis-report/appb.html
    October 01, 2015 - Health Outcomes Reported in Transforming Primary Care Studies Study/PI Chronic Disease … the Spread of Group Health's Medical Home Robert Reid, MD, MPH, PhD Diabetes Cardiovascular disease … blood pressure target TransforMN Study Leif Solberg, MD Diabetes Cardiovascular disease … Diabetes: HbA1c ≤7% Blood pressure ≤130/80 mm Hg LDL cholesterol ≤100 mg/dL Cardiovascular disease

59. Appendix B. Health Outcomes Reported in Transforming Primary Care Studies | Agency for Healthcare Research and Quality
    www.ahrq.gov/ncepcr/reports/grants-transform/health-outcomes-reported.html
    March 01, 2017 - Health Outcomes Reported in Transforming Primary Care Studies Study/PI Chronic Disease … the Spread of Group Health's Medical Home Robert Reid, MD, MPH, PhD Diabetes Cardiovascular disease … TransforMN Study Leif Solberg, MD Diabetes Cardiovascular disease Diabetes: HbA1c … ≤7% Blood pressure ≤130/80 mm Hg LDL cholesterol ≤100 mg/dL Cardiovascular disease: Blood

60. Join the IDEAS Project To Advance Diagnostic Safety | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletters/e-newsletter/966.html
    July 01, 2025 - AHRQ Stats: Heart Disease in Adults by Sex .   New Research and Evidence . … Funded with AHRQ support, two novel algorithms described in Clinical Infectious Diseases   have shown … AHRQ Stats: Heart Disease in Adults by Sex Overall, 7.8 percent of U.S. adults aged 18 and older received … heart disease treatment in 2022. … Heart disease impacted 8.4 percent of men and 7.2 percent of women.